Introduction
We work to improve the life quality of people in Turkey and the world with our strong R&D organization, our state-of-the-art and value-added wide product portfolio covering all the major fields of treatment, our operations in the fields of biotechnology and consumer health based on our more than 50 years of knowledge and experience.
-
We have
a wide product portfolio covering all the major treatment areas including cardiology, central
nervous system, rare diseases and acute products. -
We created Wellcare brand in
2016 to generate right solutions to the new emerged needs and bring a new breath to the consumer
health field within the framework of our approach to handle consumer health as a whole. Wellcare
aims to offer solutions to health problems and raise the quality of life at every stage of life
as of birth with its innovative, clinically-proven, scientific and reliable after-care treatment
products that are approved by health authorities in 5 different categories: Digestive Health,
Probiotics, Allergy, Vitamins and Minerals, Cold and Cough. -
As ILKO, we had partnered with South Korean
Genexine and founded Ilkogen, the first biotechnology pharmaceutical R&D, production and
international marketing company of Turkey. Following Ilkogen that commenced operations in 2013,
we had established our Biotechnology R&D Center in 2015. At this center, we primarily work
on developing biotechnology products for cancer and cancer-related diseases. We are still
working on biosuperior, nano-biosuperior, biosimilar and next generation biotechnology products.
WE RESEARCH AND DEVELOP FOR YOUR HEALTH
We carry out our R&D operations at two different centers.
-
We develop state-of-the-art and
value-added products at ILKO ARGEM (Ilko Research and Development Center) that commenced
operations in 2009. -
We research and develop biotechnology
products at ILKO Biotechnology R&D Center that was founded within Istanbul
Technopark in 2015.
INTERNATIONAL MARKETS
As ILKO, we have the vision to expand to overseas markets and to become a global pharmaceutical company. We export our products to more than 25 countries in CIS, Middle East, Balkans, Far East, Africa and Latin America regions, and carry out regulatory activities in more than 40 countries. Based on 2017 data of World Intellectual Property Organization (WIPO), ILKO is the company that made the highest number of brand applications from Turkey in the pharmaceutical industry within the framework of Madrid Protocol. ILKO is ranked 27th among 2018's top exporters in the pharmaceutical category according to the data of Istanbul Chemicals & Chemical Products Exporters Association (IKMIB).
STRATEGIC PARTNERSHIPS
As ILKO, we enter into strategic partnerships for our production operations. The capacity of these long-term partnerships with national and international companies including Servier, a leading pharmaceutical company of the world, increases every year.